Market research
6877.HK CLSA Premium Limited
HK HKD Financial Services
Latest close
As of 30 Oct 2026
Test a moving-average rule with historical data.
Market facts
- Market cap
- 187M
- P/E ratio
- Not available
- Analyst target
- Not available
- Dividend yield
- Not available
- Beta
- 1.84
Profile
Instrument facts
- Exchange
- HK
- Currency
- HKD
- Sector
- Financial Services
- Industry
- Capital Markets
- ISIN
- KYG2R50B1046
- Market cap
- 187M
- P/E ratio
- Not available
- Analyst target
- Not available
- Dividend yield
- Not available
- Beta
- 1.84
About
About CLSA Premium Limited
Top Eminent Healthcare Group Limited, an investment holding company, sells healthcare products and other services in Australia, Hong Kong, and New Zealand. It operates through the healthcare business and unallocated segment segments. The company also provides molecular tea, Ganoderma lucidum, brain protection capsules, and natural factors. Top Eminent Healthcare Group Limited was formerly known as CLSA Premium Limited and changed its name to Top Eminent Healthcare Group Limited in May 2025. Top Eminent Healthcare Group Limited was incorporated in 2010 and is headquartered in Wan Chai, Hong Kong. As of April 1, 2025, Top Eminent Healthcare Group Limited operates as a subsidiary of Beijing Tong Ren Tang (Cayman) Limited.
Research context
CLSA Premium Limited appears in PyInvesting’s Hong Kong Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- HKD
- Sector
- Financial Services
- Industry
- Capital Markets
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
Community
Investor discussion
1 comment
Sign in to join the 6877.HK discussion.
5 years, 6 months ago
CLSA Premium Limited is currently in a long term downtrend where the price is trading 0.1% below its 200 day moving average.
From a valuation standpoint, the stock is 404.2% more expensive than other stocks from the Financial Services sector with a price to sales ratio of 74.7.
CLSA Premium Limited's total revenue sank by 27.1% to $2M since the same quarter in the previous year.
Its net income has increased by 51.0% to $-50M since the same quarter in the previous year.
Finally, its free cash flow grew by 222.6% to $19M since the same quarter in the previous year.
Based on the above factors, CLSA Premium Limited gets an overall score of 2/5.